Charline Lasnon

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

EJNMMI research

Cancer imaging : the official publication of the International Cancer Imaging Society

Diagnostics (Basel, Switzerland)

European journal of nuclear medicine and molecular imaging

Centre François Baclesse Centre de Lutte Contre le Cancer

BioTICLA INSERM U1199 / Ecole Doctorale EdNBISE (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre François Baclesse Centre de Lutte Contre le Cancer Jan 09 2016

France

Praticien spécialiste :: Nuclear Medicine

Université de Caen Basse-Normandie May 01 2014 - Aug 20 2016

France

AHU

Centre Hospitalier Universitaire de Caen May 01 2014 - Aug 20 2016

France

AHU :: Nuclear medicine

Education History

BioTICLA INSERM U1199 / Ecole Doctorale EdNBISE Sep 01 2013 - Dec 21 2016

France

PHD :: Optimisation des protocoles et de la quantification en TEP dans les domaines de la recherche clinique et pré-clinique

Université de Caen Basse-Normandie Sep 01 2011 - Jun 30 2012

France

MSC

Publications

Charline Lasnon, Adeline Morel, Nicolas Aide, Angélique Da Silva, George Emile
Baseline and early 18 F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Charline Lasnon, Adeline Morel, Nicolas Aide, Angélique Da Silva, George Emile
Baseline and early 18 F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Charline Lasnon, Adeline Morel, Nicolas Aide, Angélique Da Silva, George Emile
Baseline and early 18 F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Kathleen Weyts, Elske Quak, Idlir Licaj, Renaud Ciappuccini, Charline Lasnon, Aurélien Corroyer-Dulmont, Gauthier Foucras, Stéphane Bardet, Cyril Jaudet
Deep Learning Denoising Improves and Homogenizes Patient [ 18 F]FDG PET Image Quality in Digital PET/CT. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Kathleen Weyts, Elske Quak, Idlir Licaj, Renaud Ciappuccini, Charline Lasnon, Aurélien Corroyer-Dulmont, Gauthier Foucras, Stéphane Bardet, Cyril Jaudet
Deep Learning Denoising Improves and Homogenizes Patient [ 18 F]FDG PET Image Quality in Digital PET/CT. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Nicolas Aide, Kathleen Weyts, Charline Lasnon
Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic 18 F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Kathleen Weyts, Charline Lasnon, Renaud Ciappuccini, Justine Lequesne, Aurélien Corroyer-Dulmont, Elske Quak, Bénédicte Clarisse, Laurent Roussel, Stephane Bardet, Cyril Jaudet
Artificial intelligence-based PET denoising could allow a two-fold reduction in [ 18 F]FDG PET acquisition time in digital PET/CT. European journal of nuclear medicine and molecular imaging 49 (11) (2022)
Nicolas Aide, Laurent Poulain, Nicolas Elie, Mélanie Briand, Florence Giffard, Cécile Blanc-Fournier, Florence Joly, Charline Lasnon
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers. EJNMMI research 11 (1) (2021)
Julie Faudemer, Nicolas Aide, Anne-Claire Gac, Ghandi Damaj, Jean-Pierre Vilque, Charline Lasnon
Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma. Scientific reports 11 (1) (2021)
Elske Quak, Gilles Girault, Marie Aude Thenint, Kathleen Weyts, Justine Lequesne, Charline Lasnon
Author Gender Inequality in Medical Imaging Journals and the COVID-19 Pandemic. Radiology 300 (1) (2021)
Elske Quak, Grégoire Braux, Kathleen Weyts, Charline Lasnon
More fat, less migration: breast density as a predictor of sentinel lymph node non-visualization in breast cancer. EJNMMI research 11 (1) (2021)
Nicolas Aide, Christophe Fruchart, Catherine Nganoa, Anne-Claire Gac, Charline Lasnon
Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy. European radiology 30 (8) (2020)
Nicolas Aide, Thibault Salomon, Cécile Blanc-Fournier, Jean-Michel Grellard, Christelle Levy, Charline Lasnon
Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics. EJNMMI research 8 (1) (2018)
Nicolas Aide, Marjolaine Talbot, Christophe Fruchart, Gandhi Damaj, Charline Lasnon
Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. European journal of nuclear medicine and molecular imaging 45 (5) (2017)

Charline Lasnon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Charline Lasnon